Which trial do we need? Percutaneous mechanical aspiration versus medical management alone for treatment of right-sided valvular infective endocarditis

Molly Hillenbrand; Ahmad Mourad; Thomas L Holland; Nicholas A Turner

doi:10.1016/j.cmi.2024.02.005

Which trial do we need? Percutaneous mechanical aspiration versus medical management alone for treatment of right-sided valvular infective endocarditis

Clin Microbiol Infect. 2024 Jun;30(6):703-706. doi: 10.1016/j.cmi.2024.02.005. Epub 2024 Feb 8.

Authors

Molly Hillenbrand¹, Ahmad Mourad¹, Thomas L Holland², Nicholas A Turner³

Affiliations

¹ Division of Infectious Diseases, Department of Medicine, Duke University Medical Center, Durham, NC, USA.
² Division of Infectious Diseases, Department of Medicine, Duke University Medical Center, Durham, NC, USA; Duke Clinical Research Institute, Duke University School of Medicine, Durham, NC, USA.
³ Division of Infectious Diseases, Department of Medicine, Duke University Medical Center, Durham, NC, USA. Electronic address: nick.turner@duke.edu.

PMID: 38341142
DOI: 10.1016/j.cmi.2024.02.005

No abstract available

Keywords: Infective endocarditis; Percutaneous mechanical aspiration (PMA); Right-sided endocarditis; Transcatheter vacuum-assisted mass extraction; Tricuspid endocarditis.

Publication types

Letter

MeSH terms

Anti-Bacterial Agents / therapeutic use
Endocarditis* / drug therapy
Endocarditis* / microbiology
Endocarditis* / therapy
Endocarditis, Bacterial / drug therapy
Endocarditis, Bacterial / microbiology
Heart Valve Diseases / microbiology
Heart Valve Diseases / surgery
Heart Valve Diseases / therapy
Humans
Suction
Treatment Outcome

Substances

Anti-Bacterial Agents